N-Acetylcysteine treatment reduces TNF-α levels and myonecrosis in diaphragm muscle of mdx mice

Clinical Nutrition

Volumn 32, Issue 3, 2013, Pages 472-475

  de Senzi Moraes Pinto, Rafael ^a   Ferretti, Renato ^a   Moraes, Luis Henrique Rapucci ^a   Neto, Humberto Santo ^a   Marques, Maria Julia ^a   Minatel, Elaine ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Diaphragm muscle; Mdx mice; N Acetylcysteine; TNF

Indexed keywords

ACETYLCYSTEINE; CREATINE KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAPHRAGM MUSCLE; DRUG EFFICACY; DRUG MECHANISM; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVITY; LIPID PEROXIDATION; MOUSE; MUSCLE NECROSIS; NONHUMAN; PROTEIN EXPRESSION; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; DIAPHRAGM; DYSTROPHIN; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE, SKELETAL; NECROSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84877130849     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2012.06.001     Document Type: Article

References (16)

1. Engel A.G., Yamamoto M., Fischbeck K.H. Muscular dystrophies. Myology 1994, 1133-1187. McGraw-Hill, New York. A.G. Engel, C. Franzini-Armstrong (Eds.).
2. Grounds M., Radley H.G., Lynch G.S., Nagaraju K., De Luca A. Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy. Neurobiol Dis 2008, 31:1-19.
3. Whitehead N.P., Pham C., Gervasio O.L., Allen D.G. N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice. J Physiol 2008, 586(7):2003-2014.
4. Lawler J.M. Exacerbation of pathology by oxidative stress in respiratory and locomotor muscles with Duchenne muscular dystrophy. J Physiol 2011, 589(9):2161-2170.
5. Willians I.A., Allen D.G. The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice. Am J Physiol Heart Circ Physiol 2007, 293:H1969-H1977.
6. Stedman H.H., Sweeney H.L., Shrager J.B., Maguirre H.C., Panettieri R.A., Petrof B., et al. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 1991, 352:536-539.
7. Zafarullah M., Li W.Q., Sylvester J., Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci 2003, 60:6-20.
8. Grounds M.D., Torrisi J. Anti-TNFa (Remicade) therapy protects dystrophic skeletal muscle from necrosis. FASEB J 2004, 18:676-682.
9. Machado R.V., Maurício A.F., Taniguti A.P.T., Ferretti R., Neto H.S., Marques M.J. Eicosapentaenoic acid decreases TNF-alpha and protects dystrophic muscles of mdx mice from degeneration. J Neuroimmunol 2011, 232:145-150.
10. Tonon E., Ferretti R., Shiratori J.H., Santo Neto H., Marques M.J., Minatel E. Ascorbic acid protects the diaphragm muscle against myonecrosis in mdx mice. Nutrition 2012, 28:686-690.
11. Uchida K. 4-Hydroxyl-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 2003, 42:318-343.
12. Bani C., Lagrota-Candido J., Pinheiro D.F., Leite P.E., Salimena M.C., Henrique-Pons A., et al. Pattern of metalloprotease activity and myofiber regeneration in skeletal muscles of mdx mice. Muscle Nerve 2008, 37:83-592.
13. Patel V.B., Spencer C.H., Young T.A., Lively M.O., Cunningham C.C. Effects of 4-hydroxynonenal on mitochondrial 3-hydroxy-3-methylglutaryl (HMG-CoA) synthase. Free Radic Biol Med 2007, 43:1499-1507.
14. Culligan K., Banville N., Dowling P., Ohlendieck K. Drastic reduction of calsequestrin-like proteins and impaired calcium binding in dystrophic mdx muscle. J Appl Physiol 2002, 92:435-445.
15. Palacio J.R., Markert U.R., Martinez P. Anti-inflammatory properties of N-acetylcysteine on lipopolysaccharide-activated macrophages. Inflamm Res 2011, 60:695-704.
16. Behr J., Maier K., Degenkolb B., Krombach F., Vogelmeier C. Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Am J Respir Crit Care Med 1997, 156:1897-1901.